Biomedicines, 2022 · DOI: 10.3390/biomedicines10102513 · Published: October 8, 2022
The study investigates a bone graft substitute called HACaS+G (Cerament G), which contains calcium sulphate-hydroxyapatite loaded with gentamicin. This material aims to promote bone growth and fight infection. The researchers used a rat model with both infected and non-infected non-unions (fractures that don't heal) to see how well HACaS+G worked. The goal was to assess its ability to stimulate bone formation and combat infection. The results showed that while HACaS+G could stimulate bone formation, it didn't provide additional benefits in infected non-unions regarding bone growth or mechanical stability, especially when there were significant bone defects.
Cerament G may not be the best choice for treating infected non-unions with segmental bone defects due to its limited effect on osteoconduction and mechanical stability.
Cerament G could be used as a prophylactic measure against infections in bone grafts.
Further studies are necessary to explore combinations of bone substitutes with allogeneic or autologous bone grafting, or with osteoinductive pharmaceuticals, to enhance bone healing in infected non-unions.